User:Mr. Ibrahem/Lifitegrast
Clinical data | |
---|---|
Pronunciation | Xiidra /ˈzaɪdrə/[1] |
Trade names | Xiidra |
Other names | SAR-1118 |
AHFS/Drugs.com | Monograph |
MedlinePlus | a616039 |
Pregnancy category |
|
Routes of administration | Eye drops |
Legal status | |
Legal status | |
Identifiers | |
| |
Chemical and physical data | |
Formula | C29H24Cl2N2O7S |
Molar mass | 615.48 g·mol−1 |
3D model (JSmol) | |
| |
|
Lifitegrast, sold under the brand name Xiidra, is a medication used to treat dry eyes.[2] It is unclear if its benefits are greater than its harms.[3][4] It is used as eye drops.[2]
Common side effects include blurry vision, red eyes, headache, change in taste, and itchiness.[2] Safety in pregnancy is not clear.[5] It reduces inflammation by inhibiting T cells.[3]
Lifitegrast was approved for medical use in the United States in 2016.[2] It is not approved in either the United Kingdom or Europe.[3][4] In the United States it costs about 580 USD per month as of 2021.[6]
References[edit]
- ^ "Patient information: Xiidra® (ZYE-druh) (lifitegrast ophthalmic solution) 5% for topical ophthalmic use" (PDF). Novartis. June 2020. Archived (PDF) from the original on 2021-02-13. Retrieved 2021-02-05.
- ^ a b c d e f "Lifitegrast Monograph for Professionals". Drugs.com. Archived from the original on 5 March 2021. Retrieved 22 November 2021.
- ^ a b c "Lifitegrast". SPS - Specialist Pharmacy Service. 8 February 2016. Archived from the original on 11 December 2021. Retrieved 23 November 2021.
- ^ a b "Xiidra: Withdrawal of the marketing authorisation application". Archived from the original on 14 November 2021. Retrieved 23 November 2021.
- ^ "Lifitegrast ophthalmic (Xiidra) Use During Pregnancy". Drugs.com. Archived from the original on 28 November 2020. Retrieved 23 November 2021.
- ^ "Lifitegrast Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 28 October 2016. Retrieved 23 November 2021.